Physical Activity Intervention to Reduce Functional Health Disparities Among Breast Cancer Survivors
- Conditions
- Breast CancerPhysical Activity
- Registration Number
- NCT02763228
- Lead Sponsor
- Case Comprehensive Cancer Center
- Brief Summary
The purpose of this research study is to determine whether a physical activity (exercise) program in the community will improve the functional and overall health status of older women with a history of breast cancer. The physical activity or exercise program is designed for all older breast cancer survivors, and in particular for African-Americans and women of lower socio-economic status, who are the least likely to engage in physical activity.
- Detailed Description
Specific Aim #1: To determine the effect of a refined and culturally-sensitive physical activity intervention on functional outcomes at 20 and 52 weeks among older Breast Cancer survivors who are within five years of treatment completion for stage I-III Breast Cancer (BCa).
Specific Aim #2: To examine whether race and socioeconomic status (SES) moderate the intervention effect on physical activity (PA) levels and functional outcomes at 20 and 52 weeks.
Specific Aim #3: To examine the effect of the PA intervention on longitudinal changes in beliefs, attitudes and preferences (KAPs) and PA levels, and the extent to which changes in these factors mediate intervention effect on functional outcomes.
Specific Aim #4: To determine the effect of the PA intervention on surrogate biomarkers associated with breast cancer prognosis and functional disability.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 218
- Pathologically confirmed breast cancer
- Stage I-III
- Patients who have completed treatment but are within five years of treatment completion (primary surgery, chemotherapy or radiation therapy), whichever was received last. Hormonal therapy and targeted therapy are allowed
- Race: African-Americans and Non-Hispanic Whites
- Stage IV breast cancer
- Patients with end-stage disease, severe dementia and/or life expectancy of less than one year
- Inability to understand English as study instruments have not been validated in other languages
- Inability to provide informed consent
- High-risk patients (as defined by the American College of Sports Medicine risk-stratification schema using the American College of Sports Medicine (ACSM)/American Heart Association exercise pre-participation questionnaire) who do not receive clearance from cardiology
- Other medical or psychological conditions that would make participation unsafe or inhibit our ability to test our primary hypothesis, e.g. Parkinson's disease, severe dementia.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Change in physical performance scores based on the Short Physical Performance Battery (SPPB) baseline to 20 weeks Change in physical performance will be ascertained using the Short Physical Performance Battery (SPPB). Summary scores range from 0-12 and higher scores denote higher physical performance.
- Secondary Outcome Measures
Name Time Method Change in SPPB scores baseline to 52 weeks Change in physical performance will be ascertained using the Short Physical Performance Battery (SPPB). Summary scores range from 0-12 and higher scores denote higher physical performance.
Change in Activities of daily living (ADL) score baseline to 52 weeks Summary scores for ADL range from 0-14 and higher scores denote higher functional status.
Trial Locations
- Locations (3)
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
🇺🇸Cleveland, Ohio, United States
Metro Health Medical Center
🇺🇸Cleveland, Ohio, United States
Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center
🇺🇸Cleveland, Ohio, United States
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center🇺🇸Cleveland, Ohio, United States